Most data on the importance of PI3K and AKT in the modulation of AR function and effects on prostate cancer proliferation were generated with specific inhibitors, thus providing strong evidence for the relevance of the pathway for therapeutic targeting [148]. This evidence concerns the gene PIK3CA and Familial prostate cancer.